a year ago
ASRT
AnalystsThomas FlatenThomas Flaten's Stock Forecasts
AnalystsThomas Flaten
Analyst Ranking
Bottom 9%
#4288 out of 4695 analysts
Average Return
-3.75%
Win Rate
31%9 out of 29
Risk vs Reward
Poor
Good
Thomas Flaten's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Personalis IncPSNL | +253.06% | $1.47 | $5.19 | 2024-04-30 - 2024-10-04 | Strong Buy |
Diamedica Therapeutics IncDMAC | +220.63% | $1.26 | $4.04 | 2022-07-07 - 2023-07-06 | Strong Buy |
Biolife Solutions IncBLFS | +152.95% | $15.77 | $39.89 | 2020-02-24 - 2021-02-24 | Strong Buy |
Castle Biosciences IncCSTL | +101.72% | $11.66 | $23.52 | 2023-06-05 - 2024-06-04 | Strong Buy |
Biolife Solutions IncBLFS | +73.46% | $13.11 | $22.74 | 2023-08-09 - 2024-08-08 | Strong Buy |
Thomas Flaten Analyst Color
Get additional color on Thomas Flaten's coverage of popular stocks
Thomas Flaten's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Journey Medical CorpDERM | 1 | Strong Buy | $9.00 | +37.83% | Initiates Coverage On | a month ago |
Optinose IncOPTN | 3 | Strong Buy | $3.00 | +321.94% | Maintains | 5 months ago |
Personalis IncPSNL | 1 | Strong Buy | $4.00 | -22.93% | Initiates Coverage On | 5 months ago |
Dermtech IncDMTKQ | 1 | Hold | $0.63 | +570.21% | Downgrades | 6 months ago |
Assertio Holdings IncASRT | 3 | Strong Buy | $3.00 | +163.16% | Maintains | 7 months ago |
Aquestive Therapeutics IncAQST | 1 | Strong Buy | $8.00 | +61.62% | Maintains | 7 months ago |
Achieve Life Sciences IncACHV | 3 | Strong Buy | $11.00 | +119.12% | Maintains | 7 months ago |
Checkpoint Therapeutics IncCKPT | 3 | Strong Buy | $14.00 | N/A | Maintains | a year ago |
Better Therapeutics IncBTTX | 2 | Strong Buy | $3.00 | N/A | Maintains | a year ago |
Biolife Solutions IncBLFS | 2 | Strong Buy | $25.00 | N/A | Maintains | a year ago |
Castle Biosciences IncCSTL | 4 | Strong Buy | $32.00 | N/A | Reiterates | a year ago |
Evaxion Biotech AEVAX | 1 | Strong Buy | $70.00 | N/A | Maintains | 2 years ago |
Oncocyte CorpOCX | 3 | Hold | $10.00 | N/A | Downgrades | 2 years ago |
Diamedica Therapeutics IncDMAC | 1 | Strong Buy | $8.00 | N/A | Maintains | 2 years ago |
Fresh Tracks Therapeutics IncFRTX | 2 | Hold | N/A | N/A | Downgrades | 2 years ago |
Ensysce Biosciences IncENSC | 1 | Strong Buy | $960.00 | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.